195 related articles for article (PubMed ID: 31269226)
1. Validation of the triple timed up-and-go test in Lambert-Eaton myasthenia.
Raja SM; Sanders DB; Juel VC; Harati Y; Smith AG; Pascuzzi R; Richman DP; Wu A; Aleš KL; Jacobus LR; Jacobus DP; Guptill JT;
Muscle Nerve; 2019 Sep; 60(3):292-298. PubMed ID: 31269226
[TBL] [Abstract][Full Text] [Related]
2. Reliability of the triple-timed up-and-go test.
Sanders DB; Guptill JT; Aleš KL; Hobson-Webb LD; Jacobus DP; Mahmood R; Massey JM; Pittman MM; Prather K; Raja SM; Yow E; Juel VC
Muscle Nerve; 2018 Jan; 57(1):136-139. PubMed ID: 28545168
[TBL] [Abstract][Full Text] [Related]
3. 3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia.
Sanders DB; Juel VC; Harati Y; Smith AG; Peltier AC; Marburger T; Lou JS; Pascuzzi RM; Richman DP; Xie T; Demmel V; Jacobus LR; Aleš KL; Jacobus DP;
Muscle Nerve; 2018 Apr; 57(4):561-568. PubMed ID: 29280483
[TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetics/Pharmacodynamics of 3,4-Diaminopyridine Free Base in Patients With Lambert-Eaton Myasthenia.
Thakkar N; Guptill JT; Aleš K; Jacobus D; Jacobus L; Peloquin C; Cohen-Wolkowiez M; Gonzalez D;
CPT Pharmacometrics Syst Pharmacol; 2017 Sep; 6(9):625-634. PubMed ID: 28623849
[TBL] [Abstract][Full Text] [Related]
5. Treatment for Lambert-Eaton myasthenic syndrome.
Maddison P; Newsom-Davis J
Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
[TBL] [Abstract][Full Text] [Related]
6. Treatment for Lambert-Eaton myasthenic syndrome.
Maddison P; Newsom-Davis J
Cochrane Database Syst Rev; 2005 Apr; (2):CD003279. PubMed ID: 15846654
[TBL] [Abstract][Full Text] [Related]
7. Treatment for Lambert-Eaton myasthenic syndrome.
Keogh M; Sedehizadeh S; Maddison P
Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD003279. PubMed ID: 21328260
[TBL] [Abstract][Full Text] [Related]
8. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.
Schneider I; Kornhuber ME; Hanisch F
J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up in infantile-onset lambert-eaton myasthenic syndrome.
Portaro S; Parisi D; Polizzi A; Ruggieri M; Andreetta F; Bernasconi P; Toscano A; Rodolico C
J Child Neurol; 2014 Sep; 29(9):NP58-61. PubMed ID: 24114606
[TBL] [Abstract][Full Text] [Related]
10. 3,4-Diaminopyridine for the treatment of myasthenia gravis with electrophysiological patterns of Lambert-Eaton myasthenic syndrome.
Lee MK; Sunwoo IN; Kim SM
J Clin Neurosci; 2018 Apr; 50():194-198. PubMed ID: 29402568
[TBL] [Abstract][Full Text] [Related]
11. Amifampridine tablets for the treatment of Lambert-Eaton myasthenic syndrome.
Mantegazza R
Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1013-1018. PubMed ID: 31639317
[No Abstract] [Full Text] [Related]
12. [Autoimmune myasthenia and Lambert-Eaton myasthenic syndrome. Physiopathologic concepts].
Eymard B
Ann Med Interne (Paris); 1989; 140(6):462-6. PubMed ID: 2696402
[TBL] [Abstract][Full Text] [Related]
13. Palliative care for a patient with Lambert-Eaton myasthenic syndrome: role of 3,4-diaminopyridine.
Chan KY; Chang RS; Lau VW; Chan ML; Lai T
Ann Palliat Med; 2016 Oct; 5(4):311-314. PubMed ID: 27506750
[TBL] [Abstract][Full Text] [Related]
14. 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome: Concerns regarding presentation of previous studies.
Oh SJ
Muscle Nerve; 2018 May; 57(5):E130. PubMed ID: 29406572
[No Abstract] [Full Text] [Related]
15. Lambert Eaton myasthenic syndrome.
Petty R
Pract Neurol; 2007 Aug; 7(4):265-7. PubMed ID: 17636143
[No Abstract] [Full Text] [Related]
16. [Favourable outcome after treatment with rituximab in a case of seronegative non-paraneoplastic Lambert-Eaton myasthenic syndrome].
Boutin E; Rey C; Romeu M; Pouget J; Franques J
Rev Med Interne; 2013 Aug; 34(8):493-6. PubMed ID: 23759215
[TBL] [Abstract][Full Text] [Related]
17. Myasthenia gravis Lambert-Eaton overlap syndrome.
Oh SJ
Muscle Nerve; 2016 Jan; 53(1):20-6. PubMed ID: 26418033
[TBL] [Abstract][Full Text] [Related]
18. Lambert-Eaton myasthenic syndrome in childhood.
Kostera-Pruszczyk A; Ryniewicz B; Rowinska-Marcinska K; Dutkiewicz M; Kamińska A
Eur J Paediatr Neurol; 2009 Mar; 13(2):194-6. PubMed ID: 18585938
[TBL] [Abstract][Full Text] [Related]
19. 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome.
McEvoy KM; Windebank AJ; Daube JR; Low PA
N Engl J Med; 1989 Dec; 321(23):1567-71. PubMed ID: 2555713
[TBL] [Abstract][Full Text] [Related]
20. [A case of Lambert-Eaton myasthenic syndrome with small cell lung cancer, treated with 3,4-diaminopyridine].
Uekita K; Ishida T; Sekine S; Ishii T; Sato S; Sugawara A; Tachihara M; Watanabe K; Kanazawa K; Saito J; Tanino Y; Munakata M
Nihon Kokyuki Gakkai Zasshi; 2009 Jan; 47(1):76-80. PubMed ID: 19198242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]